AGC Partners Advises Qforma on its Sale to SkilaMederi
Transaction Details
AGC Partners is pleased to announce that its client, Qforma, a leading HCIT company focused on advanced analytics and pharmaceutical solutions, has agreed to be acquired by SkilaMederi, a BelHealth portfolio company providing analytics, software, and consulting solutions for life sciences companies to improve their go-to-market and in-market brand strategies. Qforma and SkilaMederi will be merged together to create the market leader in pharmaceutical and healthcare analytics. With a team led by Hugh Hoffman, AGC Partners acted as sole financial advisor to Qforma. This marks AGC’s second HCIT deal in 2013, following the sale of Acuo Technologies to Lexmark back in January.
Testimonial
“We are very pleased with Hugh and his team at AGC, who were exemplary every step of the way in finding the best outcome for our shareholders," said Roger Jones, CEO of Qforma. “Hugh’s guidance was invaluable throughout the process, and I hope to be able to work with Hugh and his team again in the future.”
Related Transactions
Related Insights
Related Insights
© In the U.S., America’s Growth Capital, LLC dba AGC Partners, member FINRA/SIPC. In Europe, America’s Growth Capital Europe, LLP (Appointed Representative Alternatives St. James, LLP which is authorized and regulated by the Financial Conduct Authority). America’s Growth Capital Europe, LLP is a Limited Liability Partnership incorporated in England and Wales (OC368580). Its registered address is 6th Floor, 9 Appold Street, London EC2A 2AP. The testimonials contained herein may not be representative of the experience of other customers or clients. Testimonials are no guarantee of future performance or success. Deals marked with an “*” are non-AGC deals.
